10:30 ET -- Johnson & Johnson is one of the most mentioned companies in the U.S. across all news items in the past 12 hours, according to Factiva data. Johnson & Johnson has struck a $13.1 billion deal to buy Shockwave Medical, extending the healthcare giant's position in cardiovascular intervention. Johnson & Johnson said it will buy, for $335 a share in cash, Shockwave, a medical-device company. J&J said it expects to fund the deal with cash on hand and debt, adding that the $13.1 billion enterprise value includes cash acquired. Dow Jones & Co. owns Factiva. (chris.wack@wsj.com)


(END) Dow Jones Newswires

04-05-24 1047ET